Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
2025 comprehensive formulary, Kaiser Permanente 2025 Medicare Part D comprehensive formulary, Kaiser Permanente Criteria-based consultation prescribing program (injectable semaglutide), Kaiser Permanente Northwest Region Novo Nordisk receives FDA approval of Ozempic (semaglutide) injection for the treatment of adults with Type 2 diabetes, PR Newswire (2017) Understanding drug tiers, Patient Advocate Foundation Drug formulary (covered drugs), Kaiser Permanente Find out if your insurance covers Ozempic, NovoCare Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
University WMCoC
Other batches of this product have been endotoxin-tested see test history
Liraglutide Liraglutide is a GLP-1 receptor agonist like semaglutide that helps control blood sugar and aids in weight loss in overweight or obese people
US$ 27.87
US$ 20.46
US$ 22.27
US$ 26.78
US$ 24.74
US$ 20.07
US$ 24.69
US$ 23.29
US$ 28.00
US$ 22.87
US$ 28.39
US$ 21.42
US$ 20.73
US$ 28.37
